Literature DB >> 3026711

Collagenase chemonucleolysis via epidural injection. A review of 252 cases.

K H Chu.   

Abstract

Since 1975, collagenase has been injected into 252 herniated intervertebral discs for treatment of sciatica. Highly purified preparations of Chinese collagenase were extracted from Clostridium histolyticum CH 1093 in lyophylized form, which had a specific collagenolytic activity. It had a wide margin of safety as proven by repeated experiments in dogs by means of intradiscal, extradural, intradural, and intravenous injections. One hundred to two hundred units of collagenase dissolved in 5 ml of normal saline was injected epidurally in front of the line joining posterior vertebral body margins. The basic assumption is that the injected enzyme digested the nucleus pulposis. Symptoms disappeared or improved gradually within three to eight weeks. The total success rate was about 77%. For recurrent cases of those with less than satisfactory results, reinjections were performed without any visible antigenic reactions or neurologically adverse effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3026711

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Crystallization and preliminary X-ray characterization of the catalytic domain of collagenase G from Clostridium histolyticum.

Authors:  Ulrich Eckhard; Dorota Nüss; Paulina Ducka; Esther Schönauer; Hans Brandstetter
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-04-24

2.  Protease with collagenolytic activity produced by Bacillus sp. DPUA 1728 from Amazonian soil.

Authors:  Lorena A Lima; Raimundo F Cruz Filho; Januário G dos Santos; Wilson C Silva
Journal:  Braz J Microbiol       Date:  2015-10-27       Impact factor: 2.476

3.  A universal strategy for high-yield production of soluble and functional clostridial collagenases in E. coli.

Authors:  Paulina Ducka; Ulrich Eckhard; Esther Schönauer; Stefan Kofler; Gerhard Gottschalk; Hans Brandstetter; Dorota Nüss
Journal:  Appl Microbiol Biotechnol       Date:  2009-03-31       Impact factor: 4.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.